Driven by a passion to solve scientific challenges

Professional experience

Klaus has a demonstrated track record in leading international teams through successful life science scale-up and commercialization journeys. He brings his expertise in the stem cell field and leadership to support BioLamina through a period of accelerated scale-up and growth. Before joining BioLamina he was the Head of Cell Therapy, Commercial at Novo Nordisk, where he co-built the company’s cell therapy strategy across the value chain and helped create a product pipeline with three lead candidates moving towards first human dosing in large chronic disease areas. He was the CEO of StemMedical and led the company’s efforts to take a stem cell-based treatment from lab to patient and scaled production of an emerging technology. Prior to his focus on the cell therapy space,  Klaus also led the global commercialization of Novo Nordisk’s semaglutide molecule in metabolic disease (Ozempic® and Rybelsus®), establishing strong teams and external partnerships to drive market penetration in a mega-blockbuster therapeutic category. 

He is also a Board Member of Stimuliver, a company established of research from the University of Edinburgh, aiming at progressing a first-in-class cell-derived liver tissue implant to treat acute and chronic liver diseases for which there are limited or no treatments today.

Education

• MSc in Political Science and Economics, University of Copenhagen, Denmark

Professional experience

Therése is a multilateral life science leader and a key member at BioLamina since its beginning. She has consistently worked in roles combining scientific knowledge and commercial aptitude such as within Business Development, Product Management, Marketing and Sales. Prior to her work at BioLamina, Therése worked a couple of years as a post-doc at Max-Planck-Institute for Neurological Research in Cologne, Germany.

Education

• PhD in Neurobiology, Lund University, Sweden
• MSc in Molecular biology, Lund University, Sweden
• BSc in Psychology, Lund University, Sweden

Professional experience

Ulrika is an experienced life science leader with a demonstrated history of senior management in the pharmaceutical and biotechnology industry. Before working as BioLamina, she was a consultant in Life Science Operations/CMC, Leadership & Project Management. She previously worked as Site Manager at CDMO Cobra Biologics (mamalian cell) and as Head of Projects & Process Technology at Recipharm Oral Solid Dosages site for Antibiotics. Prior to this experience, she worked at AstraZeneca on various positions such as Head of API Process Technology (small molecules) and Head of Pilot Plant AZ Bio PR&D (biologics API).

Education

• MSc, Chemical Engineering/Biochemistry, KTH Royal Institute of Technology, Stockholm, Sweden and University of Sydney, Australia
• Business Certificate in Manufacturing Excellence, University of Warwick, UK

Professional experience

Hilja has a strong experience in Quality and Management in the life science industry. Prior to her current position, Hilja has been Head of Quality Control at ProPharma, Director Quality Assurance, Head of QA at Ardena AB and Group leader VGQM QC Microbiology at Recipharm. She previously had a consulting company in the life science and pharmaceutical industries.

Education

• Ph.D., Medicine, Gothenburg University, Sweden

• Chemical engineering, KTH Royal Institute of Technology, Stockholm, Sweden

Professional experience

Brian has over 20 years of combined academic and corporate experience and is an internationally renowned authority on cell therapy manufacturing, iPSC development, and cryopreservation. Brian completed his postdoctoral training at the University of Pennsylvania School of Medicine before becoming an assistant professor and founding member of the Mitochondria and Metabolism Center at the University of Washington School of Medicine in Seattle. He transitioned to industry as Scientific Applications Director at BioLife Solutions, where he helped numerous groups overcome their manufacturing and cryopreservation challenges for the first cell therapy products. Prior to joining BioLamina, Brian served as Chief Technology Officer at Pluristyx, where he helped build their gene-modified induced Pluripotent Stem Cell (iPSC) platform as a universal, off-the-shelf starting material for the clinical manufacturing of next generation cell-based products. Dr. Hawkins is a member of multiple national focus groups that work to advance the development of regenerative medicine and cell therapy products and led the PDA/ANSI cryopreservation standard project that was recognized as a voluntary standard by the US FDA’s Center for Biologics Evaluation and Research (CBER).

Education

• PhD, Molecular Cell Biology and Biotechnology, Virginia Polytechnic Institute and State University 

Professional experience

Anders has a long array of experience in Life Science industry in general and with BioLamina in particular. Joining the company in 2011 as Project Manager, he has since held many roles within the company. Prior to his current position as VP Strategic Development, other roles held at BioLamina include COO and interim CEO.

Experience outside of BioLamina include working as independent consultant for pharmaceutical and medical device industries, holding the position of COO at Cadila Pharmaceuticals Sweden, and working at both Anocca and SentoClone (Quality Manager and Project Manager) with setup of new laboratories and QMS for cell-based medicinal products.

Education

• M.Sc. in Industrial Engineering and Business Management, KTH Royal Institute of Technology, Stockholm, Sweden

Professional experience

Lisa has over 20 years of experience in human resources and fostering talents. Before joining BioLamina, Lisa supported the growth journey of OX2 as Group Talent Manager. She previously worked at Skanska Group as Vice President Talent Management then Vice President Talent & Culture, where she led a team of specialists within HRIS, Talent management, leadership development, Diversity & Inclusion and employee engagement. Lisa’s experience includes HR management roles within various industries such as IT, Facility Services and Pharmaceuticals.

Education

• Master’s Degree in Human Resources Management, University of Umeå, Sweden

Professional experience

Magnus has more than 25 years of experience in finance and management, from different sectors and businesses.

Prior to his current position at BioLamina, he worked as Managing Director for Nytida, the largest business area within the listed Nordic healthcare group Ambea. He has also been the Managing Director of Keaolis Sverige. He has previously been CFO at ISS Facility Services, M2 Engineering and Spendrups Bryggeri.

Education

• BSc in Finance, Stockholm School of Economics, Sweden
• MBA in General Management, Darden School of Business, University of Virginia, USA